UK Human Fertilisation and Embryology Act created, effective October 2009
This article was originally published in Clinica
UK legislation enabling stem cell research using human-animal embryos received royal assent yesterday. The Human Fertilisation and Embryology Act, which updates 1990 legislation, will come into force mainly in October 2009 (the provisions related to parenting become effective in April). The Act will "keep the UK at the forefront of developments in treatment and research", said the Department of Health, citing Alzheimer's disease and cystic fibrosis as being among its most obvious beneficiaries.
You may also be interested in...
Public Company Edition: Lixte’s small uplisting was the only biopharma initial public offering in the US during Thanksgiving week, but IPOs are ramping up again. Also, LifeSci launched its second SPAC and in follow-on offerings Reata brought in $281m and Intellia grossed $175m.
Orladeyo is the first oral prophylactic approved in the US for hereditary angioedema, with Japan and EU approvals expected to follow. Pricing of $485,000 a year undercuts segment leader.
Results of Study to Assess Statin Residual Risk with Epanova in High Cardiovascular Risk Patients with Hypertriglyceridemia “should prompt reconsideration of [OTC] mixed omega-3 fatty acid products for [atherosclerotic cardiovascular disease] prevention,” say cardiologists in an editorial published with JAMA study.